Biosynex SA operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biosynex SA with three other
pharmaceutical manufacturers in Europe:
Les Trois Chenes
sales of 27.34 million Euro [US$31.50 million]
(27.72 million Euro [US$31.93 million]
Horizon Discovery Group PLC
based in the United Kingdom
(£24.07 million [US$31.35 million]
of which 53%
During the year ended December of 2016, sales at
Biosynex SA were 27.00 million Euro (US$31.11 million).
increase of 34.1%
versus 2015, when the company's sales were 20.13 million Euro.
This was the fifth consecutive year of sales increases at Biosynex SA
(and since 2011, sales have increased a total of 2,470%).